ACE Report Cover
Addition of epinephrine to popliteal nerve block does not extend analgesia in ankle fusion
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Idioma
Download Download Download
Descarregar
Cite this Report Cite this Report Cite this Report
Citar
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoritos
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Idioma
Download Download Download
Descarregar
Cite this Report Cite this Report Cite this Report
Citar
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoritos
FOOT & ANKLE
Addition of epinephrine to popliteal nerve block does not extend analgesia in ankle fusion .
Verified
This report has been verified by one or more authors of the original publication.

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2015;3(19):7 BMC Anesthesiol. 2015 Jul 10;15:100

38 patients patients scheduled for ankle fusion and/or subtalar fusion under continuous popliteal sciatic nerve block were randomized to receive 30 mL ropivacaine (0.75%) with or without the addition of epinephrine (5 ug/mL). The purpose of the study was to determine how the duration of postoperative analgesia was affected by the addition of epinephrine, as measured by the time elapsed from poplitear catheter placement until the time of first request for postoperative analgesia via patient controlled analgesia. Results indicated that the duration of postoperative analgesia was not significantly increased with the addition of epinephrine to ropivacaine for continuous popliteal nerve block.


Detalhes do financiamento da publicação +
Financiamento:
Non-Industry funded
Patrocinador:
Internal funds from the department of Anaesthesiology, Sint Maartenskliniek, Nijmegen, The Netherlands.
Conflitos:
None disclosed

Risco de viés

8/10

Critérios de notificação

19/20

Índice de Fragilidade

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sim = 1

Incerto = 0,5

Não relevante = 0

Não = 0

A Avaliação dos Critérios de Relato avalia a transparência com que os autores relatam as caraterísticas metodológicas e do ensaio na publicação. A avaliação está dividida em cinco categorias que são apresentadas de seguida.

3/4

Randomization

4/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

O Índice de Fragilidade é uma ferramenta que auxilia na interpretação de achados significativos, fornecendo uma medida de força para um resultado. O Índice de Fragilidade representa o número de eventos consecutivos que precisam de ser adicionados a um resultado dicotómico para que o resultado deixe de ser significativo. Um número pequeno representa um resultado mais fraco e um número grande representa um resultado mais forte.

Porque é que este estudo era necessário agora?

Peripheral nerve block is often used for analgesia in ankle surgery. While the choice of local anaesthetic agent used in popliteal nerve blocks impacts efficacy, it has been suggested that so too does the addition of epinephrine. The theory behind the addition of epinephrine to local anaesthetic is to reduce local plasma concentration via vasoconstriction and slow absorption, thereby increasing the duration of analgesia. The current literature was limited in relation to this treatment, and thus the present study was conducted.

Qual era a principal questão de investigação?

In ankle and subtalar fusion under popliteal nerve block, how does time to first request for postoperative anaglesia compare between blocks performed with 30 mL ropivacaine (0.75%), with and without the addition of epinephrine?

Caraterísticas do estudo +
População:
38 patients (18 years of age or older) scheduled for ankle fusion and/or subtalar fusion under continuous popliteal sciatic nerve block. All patients received paracetamol 1000mg orally 3x/day and etoricoxib 90mg orally once/day, starting on the morning of surgery for at least 7 days. Patient controlled analgesia (PCA) (GemStar, Hospira Inc) was used for postoperative analgesia, with bolus doses of 10mL ropivacaine 0.2% and 15 minute lock out time, and max dose of 30mL/4hours. If patients still needed pain medication, they received morphine 0.1-0.15 mg/kg every 4 hours subcutaneously (30 completed follow-up).
Intervenção:
ROPI-EPI group: received ultrasound guided continuous popliteal nerve block with 30 mL ropivacaine (0.75%) with epinephrine (5 ug/mL) (n=18, 15 completed follow-up, Mean age: 56 +/- 11, 9M/6F).
Comparação:
ROPI group: received ultrasound guided continuous popliteal nerve block with 30 mL ropivacaine (0.75%) without epinephrine (n=20, 15 completed follow-up, Mean age: 61 +/- 7, 8M/7F).
Resultados:
The primary outcome measure was the duration of postoperative analgesia defined as the time to first request for postoperative analgesia (TTFR) via PCA, where TTFR was defined as the time elapsed from t=0 (placement of popliteal catheter) until the time of first request. Secondary outcomes included the onset of sensory and motor block, and Numeric Rating Scale (NRS) score for pain at rest and during movement. Sensory block, as well as motor function of the tibial (plantar flexion foot) and peroneal nerve (dorsal flexion of the foot), were scored on a three point scale (0=absent, 1=partial, 2=complete).
Métodos:
RCT, prospective, double-blinded, single-centered.
Tempo:
Outcomes were assessed immediately, at 24h, and at 48h postoperatively.
Quais foram os resultados importantes?
  • Median [interquartile range] TTFR for postoperative analgesia was 463 [300-1197] min in the ROPI group and 830 [397-1128] min in the ROPI-EPI group; the difference between groups in TTFR was not statistically significant (p=0.56).
  • There was no significant difference noted between groups in terms of NRS rest at 24 h (p=0.70), NRS movement at 24 h (p=0.47), NRS max during 24 h (p=0.17), or NRS satisfaction with the block (p=0.08).
  • In the ROPI group, 4 patients received complete block in tibial sensory, 10 in tibial motor, 12 in peroneal sensory, and 11 in peroneal motor. In the ROPI-EPI group, 9 patients received complete block in tibial sensory, 9 in tibial motor, 11 in peroneal sensory, and 10 in peroneal motor.
  • No patients displayed signs of local anesthetic toxicity or inadvertent intravascular injection of epinephrine.
De que é que me devo lembrar mais?

Duration of postoperative analgesia, as measured by the time to first request for postoperative analgesia, was not significantly increased via the addition of epinephrine to ropivacaine for popliteal nerve block in ankle and/or subtalar fusion. Additionally, no significant differences were noted in any clinical outcome between the group receiving epinephrine and the group that did not.

Como é que isto afectará o tratamento dos meus doentes?

The results of this study indicate that the addition of epinephrine to ropivacaine treatment in popliteal nerve block may not significantly increase the duration of postoperative analgesia. Further high quality evidence, including larger sample sizes, is required before firm decisions regarding the use of epinephrine in this treatment are made in the clinical field.

AVISO LEGAL

O conteúdo desta página destina-se apenas a fins informativos e não pretende substituir o aconselhamento, diagnóstico ou tratamento médico profissional. Se necessitar de tratamento médico, procure sempre o conselho do seu médico ou dirija-se ao serviço de urgência mais próximo. As opiniões, crenças e pontos de vista expressos pelos indivíduos no conteúdo encontrado nesta página não reflectem as opiniões, crenças e pontos de vista da OrthoEvidence.

0 de 4 artigos mensais GRATUITOS desbloqueados
Atingiu o seu limite de 4 visualizações de artigos gratuitos este mês

Aceda à OrthoEvidence por apenas $1,99 por semana.

Mantenha-se ligado às últimas evidências. Cancele a qualquer altura.
  • Avaliações críticas dos mais recentes ensaios clínicos aleatórios de alto impacto e revisões sistemáticas em ortopedia
  • Acesso ao conteúdo do podcast OrthoEvidence, incluindo colaborações com o Journal of Bone and Joint Surgery, entrevistas com cirurgiões reconhecidos internacionalmente e discussões em mesa redonda sobre notícias e tópicos ortopédicos
  • Subscrição do The Pulse, um boletim informativo duas vezes por semana baseado em evidências, concebido para o ajudar a tomar melhores decisões clínicas
Upgrade
Close Dialog
Bem-vindo de volta!
Esqueceu-se da palavra-passe?
Comece hoje o seu teste GRATUITO!

A sua conta será afiliada a
e inclui acesso gratuito ao OrthoEvidence


OU
Esqueceu-se da palavra-passe?

OU
Verifique o seu e-mail

Se existir uma conta com o endereço de e-mail fornecido, ser-lhe-á enviado um e-mail de reposição da palavra-passe. Se não vir uma mensagem de correio eletrónico, verifique a sua pasta de spam ou de lixo eletrónico.

Para obter mais assistência, contacte a nossa equipa de apoio.

Inicie sessão para ativar esta funcionalidade

Para aceder a esta funcionalidade, tem de iniciar sessão numa conta OrthoEvidence ativa. Inicie a sessão ou crie uma conta de avaliação GRATUITA.

Traduzir o Relatório ACE

A OrthoEvidence utiliza um serviço de tradução de terceiros para tornar o conteúdo acessível em vários idiomas. Tenha em atenção que, embora sejam feitos todos os esforços para garantir a exatidão, as traduções podem nem sempre ser perfeitas.

Como citar isto ACE Report

OrthoEvidence. Addition of epinephrine to popliteal nerve block does not extend analgesia in ankle fusion. OE Journal. 2015;3(19):7. Available from: https://myorthoevidence.com/AceReport/Show/addition-of-epinephrine-to-popliteal-nerve-block-does-not-extend-analgesia-in-ankle-fusion

Copie a citação
Inicie sessão para ativar esta funcionalidade

Para aceder a esta funcionalidade, tem de iniciar sessão numa conta OrthoEvidence ativa. Inicie a sessão ou crie uma conta de avaliação GRATUITA.

Funcionalidade de Membro Premium

Para aceder a esta funcionalidade, tem de ter sessão iniciada numa conta Premium da OrthoEvidence.

Partilhe isto ACE Report